Advertisement Press Releases Archive - Page 182 of 233 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • Olink Bioscience Introduces a New and Improved Duolink Product Line

    Olink Bioscience expands its product portfolio by launching three new products, the Duolink® II reagent kit, Duolink® ImageTool, and Duolink® II Probemaker. The original Duolink product line, introduced on the market in 2007, has been well received by academic labs and pharma companies for its unique and enabling features to visualize and locate native protein-protein interactions and low abun-dant proteins in fixed cells and tissues. The new, updated version of the Duolink kit offers the same unique features but is faster, better and more convenient. Together with the Im-ageTool and Probemaker Olink Bioscience is now able to offer a complete solution, from detection to image analysis, for the protein research community where these powerful tools will help elucidate disease mechanisms and signaling pathways, leading to the development of novel diagnostics and therapeutics.

  • Olink Bioscience Launches the New PROSEEK Reagent Kit, the ELISA

    Olink Bioscience launches a new product, Proseek, today. Proseek is a user-friendly open assay development reagent kit for the detection and quantification of proteins in serumsor plasma samples. It offers the same level of performance as ELISA, but uses extremely low sample volumes; 1ul is required for each reaction thus enabling the scientist to study precious bio-banked materials and plasma from small laboratory animals. The kit allows researchers to combine their antibodies with Proseek to convenirntly set up their own specific assays.

  • Chemonaut Upgrade

    The online compound sourcing application of Chemonaut has been upgraded with new features and improvements, which further increase the efficiency of compound selection and procurement processes.

  • Zeus Announces New Financial Executives

    Zeus, Inc., a global leader in material science and high performance polymer extrusions, announced that it has named Richard Palmisano as its Treasurer and Chief Financial Officer and Jennie Ciccone as Corporate Controller.

  • Fujifilm Diosynth Biotechnologies Expands Its Mammalian Cell Culture Capacity With Addition Of 1,000l Single-Use Bioreactor

    Fujifilm Diosynth Biotechnologies is expanding its existing contract manufacturing capabilities with the addition of a 1,000L Xcellerex® Single-Use Bioreactor to its RTP, North Carolina facility. This expansion reinforces the commitment to lead the global Biologics CMO industry through continuous innovation and implementation of new technologies, service delivery and quality, as announced by Japan-based parent company, FUJIFILM Corporation.